North American-based SOHM is a generic pharmaceutical manufacturer that produces and markets generic drugs, covering all major treatment categories.
SOHM Corporate Strategy vice president Shailesh Shah said that the market combined with India being the TB capital of the world, makes the market potential of the additional new generic pharmaceutical products substantial.
"With total drug spending on respiratory disease in India at approximately $600m we feel confident this product line will increase revenue as distribution begins this quarter," Shah said.